Effect of iPSC-derived NK cells with site-specific integration of CAR19 and IL24 at the rDNA locus on anti-tumor activity and proliferation. This is an ASCO Meeting Abstract from the ASCO Breakthrough ...
Despite a warning from the FDA Adverse Event Reporting System, studies have found that SGLT2 inhibitor use is not associated with an increased risk of AKI. Using a sodium-glucose cotransport 2 (SGLT2) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results